CSMBMEET2024

Philip trained at University College London and spent two years at the University of Washington, Seattle, USA before joining the School of Life Sciences at the University of Dundee, Scotland in 1971, where he still works. He was a Royal Society Research Professor from 1984-2010, Director of the Medical Research Council Protein Phosphorylation Unit from 1990-2012, and Director of the Scottish Institute for Cell Signalling from 2008-2012. He founded the Division of Signal Transduction Therapy (DSTT) in 1998, which still operates today and is Europe’s longest running collaboration between academia and the pharmaceutical industry. Philip is best known in science for helping to pioneer the field of “Protein Phosphorylation”, a biological control mechanism that regulates most aspects of cell life. He discovered enzymes that became the targets for new drugs to treat cancer and arthritis and worked out how insulin converts glucose in the blood to its storage form glycogen in muscles. 20 years ago, he switched his research and now studies the interplay between protein phosphorylation and protein ubiquitylation in regulating the innate immune system. Philip’s awards include the Prix Van Gysel of Belgian Royal Academy of Medicine (1992), the Swiss Louis Jeantet Prize for Medicine (1997), the Pfizer Award for Innovative Science in Europe (1999), the Rolf Luft Prize of the Karolinska Institute, Sweden (2006), the UK Medical Research Council’s Millennium Medal (2013) and the Albert Einstein World Award of Science from The World Cultural Council 92014. He was elected a Fellow of the Royal Societies of Edinburgh and London (1984), receiving their Royal Medals in 2004 and 2008, respectively. He has also been been elected a Foreign Associate of the National Academies of Sciences of the USA (2008) and Australia (2014). Philip has received honorary doctorates from the Universities of Linkoping (Sweden), Debrecen (Hungary) and Madrid (Spain) and from the Universities of Strathclyde, St Andrews, Abertay and Dundee in Scotland for his contributions to science.

Alain Chapel has been developing gene and cell therapy using non-human primates, immune-tolerant mice and rats to protect against the side effects of radiation. He collaborates with clinicians to develop strategies for treatment of patients after radiotherapy overexposures. He has participated in the first establishment of proof of concept of the therapeutic efficacy of mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis and over dosages of radiotherapy. He has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. He is scientific investigator of clinical phase II trial evaluating the efficacy of systemic MSC injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy

Huang Wei Ling has completed her Graduation in Medicine in Londrina State University. She is Specialist in infectious and parasitic diseases, a General Practitionerand Parenteral and Enteral Medical Nutrition Therapist. She was the In-charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, responsible for the control of all prescribed antimicrobial medication.

Swamy K B is currently working as a Professor and HOD of Clinical Anatomy, Lincoln University, Kuala Lumpur, Malaysia and has been awarded PhD by Andhra University, India. He has completed his Master’s degree (MS in Clinical Anatomy) from Andhra Medical College, India, DMCh (Maternal and Child Health) from IGNOU, New Delhi, his Medical degree (MBBS) in 1976 (KMC-Kurnool). He has expertise in human genetics, reproductive health and developmental anatomy and also he performed many researches in herbal medicine. He has been the Genetic Counselor for many institutions. He has been the former Founder Anatomist, Professor and Head of the Department for many medical schools in India as well as in Malaysia.

Dr. Bhairav Bhimrao Tawshikar Kulkarni is a renowned expert in ayurvedic medicine he is practicing for the last 8 years at Shree Siddhivinayak Ayurveda Panchakarma center as Director. He is running his two branches of Kerala panchakarma centers at Aurangabad(MS) Successfully.He established the Shree Siddhivinayak Ayurveda Panchakarma Center in Aurangabad in Indian cities, which treat thousands of patients every year from these centers over the world. Developed well equipped Panchakarma Unit at Both Centers Center over thousands of panchakarma treatments was done there as per written in Ayurved classics.

Dr Susan Joyce (H index=46, >6300 citations) graduated with a B.Sc (joint hons) from Maynooth University in Biology and Mathematics and a research PhD in host-microbe interactions. She was awarded a Marie Curie Fellowship to examine cis and trans acting factors affecting mRNA synthesis and gene expression at the Ecole Normal Superieure, Paris which included a stint at the Max Planck Institute, Berlin. Before coming to UCC, Dr Joyce was a postdoctoral scientist at Trinity College Dublin and at the University of Bath, UK. Susan Joyce (BSc, PhD, CM, PGCE) is Faculty at UCC SEFS and a PI in the UCC Food Institute and an investigator in APC Microbiome Ireland. Her research interests revolve around metabolism and altered human, host and microbial metabolic pathways, with food, that can influence health and disease. She leads a metabolomics focused research group, with expertise in diverse areas of host response through small molecule analysis (MS applications), cellular systems, gene expression and signalling readout, clinical interphase, microbial associations in terms of strain isolation, functional and phenotypic characterization including their metabolites and genetics. Areas currently under investigation include (1) metabolomic approach to identify novel biomarkers of microbial dietary ingredients in fermentation and (2) metabolomic signatures in deciphering health and ageing (3) specific microbial enzyme inhibition and applications to alter metabolomic signatures towards healthy weight gain. Susan is a recipient of DAFM and SFI funding. She is a partner in the FP7 project SOPHIA, with a focus on obesity. She represents her School and APC Microbiome Ireland in the Joint Programming Initiative (JPI) CABALA for health, where she is a partner. She has published over 90 publications including publications in leading journals including Angewande Chemie. PNAS, GUT, J Hepatol and Nature Comms. She regularly serves as a reviewer for international and national grant awards and for international journals and she is serving as an associate editor Frontiers in Nutrition and Editorial Board of Liver Research. She is actively involved in undergraduate and postgraduate teaching and research, and delivers a range of lectures in advanced metabolism at all BSc levels, and college of medicine and health students. She was (student) nominated for the Presidents Prize for Teaching (Dec 2022) and she was Research Team nominated and awarded an Irish Research Council Ally award for mentor-ship (Dec 2021). She is Director of MRes in Biochemistry and Cell Biology from 2021, which is now remodeled and recommenced as MRes in Biochemistry and Biosciences, in AY2021. She is vice-chair of the Irish Mass Spectrometry Society (IMSS) to 2022, Vice Chair of the Research Committee College of SEFS

Dr. Cheng is the founder and director of Dr. Cheng Integrative Health Center and Doctor’s Anti-Aging and Weight Loss Center, of Columbia, SC, since inception in 2003. Dr. Cheng and his colleagues take an integrative approach to help patients with chronic disease esp. diabetes, obesity, cardiovascular diseases and cancer. Dr. Cheng also serves as consultant to Shenzhen BaoAn Central Hospital and Shenzhen Medical Association, Shenzhen, Guangdong, China. Dr. Cheng is also a consultant to SuHa International Hospital, Suzhou, Jiangsu, China. Dr. Cheng serves on the editorial board of Journal of Nutritional Oncology, China and Orthomolecular Medicine News Service. In recent years, Dr. Cheng grew particularly interested in functional medicine or anti-aging medicine. The current healthcare focuses on symptomatic treatments for many diseases, ignoring the root causes. For example, when we control the blood sugar of a diabetic patient or the blood pressure of a hypertensive patient, we are only treating the symptoms. We are not doing anything to the underlying disease processes. Functional medicine tries to holistically address the disease processes in addition to the symptomatic treatment. Dr. Cheng is a Fellow and board certified anti-aging physician by the American Academy of Anti-Aging Medicine (A4M) and also a Fellow and board certified, A4m Integrative Cancer Therapy. Dr. Cheng served in the United States Army as a commissioned officer (Major) and an Army physician and completed his Army duty in Dec. 2006. While in the Army, Dr. Cheng served in various positions including Chief and Medical Director of Pathology and Laboratory Medicine, Member of Risk Management Committee, Credentialling Committee, and Staff Physician of Soldier Readiness Program, Consultant to the Shaw Air Force Base Laboratory, and College of American Pathologist Inspection Team Leader for the Greenville SC Hospital Lab Inspection.